HLA matchingとは 意味・読み方・使い方

This congeniality determination system is provided with: a database for storing information relating to a HLA (Human Leukocyte Antigen) type group owned by a user; a congeniality determination means for determining the congeniality of users based on the matching level of the HLA type groups owned by each user; and an output means for outputting the congeniality determination result.例文帳に追加

ユーザが有するHLA型の組に関する情報を保持するデータベースと、ユーザ同士の相性を各々のユーザが有するHLA型の組同士の一致度に基づいて判定する相性判定手段と、前記相性判定を行った結果を出力する出力手段とを備えた相性判定システム。 - 特許庁

HLA MATCHING DONOR-ORIGINATING ACTIVATED LYMPHOCYTE TO BE USED IN PREVENTION/TREATMENT OF TUMOR/INFECTIOUS DISEASE AND AUTOIMMUNE DISEASE AND PREPARATION MAINLY COMPOSED OF THE LYMPHOCYTE, AS WELL AS METHOD FOR MANUFACTURING THE PREPARATION, AND KIT FOR PREPARING THE PREPARATION例文帳に追加

腫瘍・感染症および自己免疫疾患の予防・治療用ＨＬＡ一致他人由来活性化リンパ球および該リンパ球を主成分とする製剤ならびに該製剤の製造方法、該製剤調製用キット - 特許庁

To provide a preparation mainly composed of a lymphocyte to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases using an HLA matching donor-originating activated lymphocyte, and also to provide a method for manufacturing the preparation and a kit for preparing the preparation.例文帳に追加

ＨＬＡ一致他人由来活性化リンパ球を用いて腫瘍および感染症および自己免疫疾患の予防・治療用の該リンパ球を主成分とする製剤ならびに該製剤の製造方法、該製剤調製用キットを供する。 - 特許庁

The preparation for a treatment comprises, as a lymphocyte for prevention/treatment of tumors/infectious diseases and autoimmune diseases, a propagated/stimulated HLA matching donor-originating activated lymphocyte and a peripheral blood-originating activated lymphocyte mainly composed of the cells.例文帳に追加

腫瘍・感染症および自己免疫疾患の予防・治療用リンパ球として、増殖・活性化させたＨＬＡ一致他人由来活性化リンパ球、および該細胞を主成分とする末梢血由来の活性化リンパ球を含有させた治療用製剤とする。 - 特許庁